The Patent Lawyer
NewsThe latest IP news – to join our panel of Patent news correspondents, please contact us
UKIPO changes AI patent examination practice following Supreme Court ruling
The UK Intellectual Property Office has issued new examination guidance following the Supreme Court's landmark ruling on AI-related patentability, setting out how examiners should approach computer-implemented inventions. The UK Intellectual Property Office (UKIPO)...
UKIPO changes AI patent examination practice following Supreme Court ruling
The UK Intellectual Property Office has issued new examination guidance following the Supreme Court's landmark ruling on AI-related patentability, setting out how examiners should approach computer-implemented inventions. The UK Intellectual Property Office (UKIPO)...
USPTO proposes new transparency rules for parties behind patent reexamination challenges
The United States Patent and Trademark Office (USPTO) has proposed requiring third-party requesters for ex parte reexamination to identify all real parties in interest behind a challenge. The proposed rule, published in the Federal Register on July 22, 2026, would add...
Delhi High Court sets out a seven-step test for patentability of mental acts under Section 3(m) of the Patents Act
The appeal arose from the refusal of Indian Patent Application No. 468/DELNP/2008 titled “Method and Arrangement for Optimising the Operational Times and Cell Change Performance of Mobile Terminals.” During the proceedings, the Court noted that despite the existence...
UK High Court upholds Novartis’ Entresto patent and SPC in Accord challenge
Novartis has successfully defended its Entresto patent protection in the UK, after the High Court rejected Accord Healthcare's challenge to the validity of the relevant patent rights and found that Accord's intended generic product would infringe. Mr. Justice Meade...
Open Invention Network celebrates 20th birthday as an IP industry innovator
The largest patent non-aggression community in history and the forerunner to many of the defensive patent management organizations today, Open Invention Network (OIN) is celebrating its 20th birthday. Since its founding in 2005, OIN has expanded the scope of its...
Celebrating World IP Day: thoughts from our Editorial Board
As World Intellectual Property Day approaches on 26 April, 2025, we asked our Editorial Board for their thoughts on this year’s focus: ‘IP and music: feel the beat of IP.’ Providing unique insight from their respective jurisdictions, our Editorial Board members...
Delete all IP law: a billionaire’s switch from proprietor to opponent
Jack Dorsey tweeted, “Delete all IP law” on April 12, 2025. It is a strange position to take, considering the co-founder of Twitter has a current estimated stake of $1 billion in X Corp. and owns Block, Inc. (formerly Square). X, formerly Twitter, currently has over...
How generative AI is forcing a rethink on obviousness
Generative AI burst into public consciousness at the end of 2022, and by January 2023, ChatGPT—one of the most popular large language models—amassed over 100 million users, becoming the fastest-growing app ever. Since then, much of the focus for intellectual property...
Artificial intelligence at the EUIPO
AI governance Artificial intelligence (AI) is at the core of the European Union Intellectual Property Office's (EUIPO) vision. Its approach to AI is human-centric, rooted in the needs and priorities of the staff, ensuring that AI serves as a helpful tool to support...
UK Government responds to the AI Action Plan
In January, the UK government set out its response to the AI Opportunities Action Plan that was developed by tech entrepreneur and Chair of Advanced Research and Invention Agency (ARIA) Matt Clifford CBE. The plan set out recommendations for the government, which...
Public interest prevails: Roche denied injunction in patent dispute
F. Hoffmann-La Roche AG (Roche) brought a Patent infringement case at the Delhi High Court against Natco Pharma Limited (Natco). The claim of Roche was based on infringement of its patent for a compound Risdiplam marketed under the brand name EVRYSDI® used in the...
Nike v. Lululemon: a landmark patent battle in the footwear industry
The ongoing legal battle between Nike and Lululemon has become a focal point in the sportswear industry, highlighting the increasing importance of intellectual property (IP) protection in a highly competitive market. The case, which began in January 2023, centers...
Pfizer and BioNTech secure PTAB victory against Moderna amid global patent disputes
Pfizer and BioNTech scored a significant win at the US Patent Trial and Appeal Board (PTAB or the Board) over COVID-19 vaccine technology. The Board invalidated all challenged claims in two of Moderna's patents related to its Spikevax COVID-19 vaccine, citing strong...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.